Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro

MA Alamri, Tahir ul Qamar M, MU Mirza, R Bhadane, SM Alqahtani, I Muneer, M Froeyen, Outi Salo-Ahen

Research output: Contribution to journalArticleScientificpeer-review

24 Citations (Scopus)

Fingerprint Dive into the research topics of 'Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro'. Together they form a unique fingerprint.

Chemical Compounds